No Picture
PUF Ventures Inc.

PUF Ventures Inc. – Dr. Cezar Khursigara, PhD Joins PUF Ventures Advisory Board

VANCOUVER, April 23, 2018 /CNW/ – PUF Ventures Inc. (“PUF” or the “Company“) (CSE: PUF) (Frankfurt: PU3) (OTCPK: PUFXF), an advanced Access to Cannabis for Medical Purposes Regulations (“ACMPR“) license applicant, is pleased to announce that the Company has appointed  Dr. Cezar […]

No Picture
PUF Ventures Inc.

PUF Ventures ACMPR Licensing Update

VANCOUVER, Feb. 8, 2018 /CNW/ – PUF Ventures Inc. (“PUF” or the “Company“) (CSE: PUF) (Frankfurt: PU3) (OTCPK: PUFXF), an advanced Access to Cannabis for Medical Purposes Regulations (“ACMPR”) license applicant, is pleased to announce Health Canada has contacted AAA Heidelberg […]

No Picture
PUF Ventures Inc.

PUF Ventures to Submit Confirmation of Readiness for Licence Under the ACMPR for London, Ontario Facility

VANCOUVER, Jan. 26, 2018 /CNW/ – PUF Ventures Inc. (“PUF” or the “Company“) (CSE: PUF) (Frankfurt: PU3) (OTCPK: PUFXF), an advanced Access to Cannabis for Medical Purposes Regulations (“ACMPR”) license applicant, is pleased to announce that in response to Health Canada’s January […]

No Picture
PUF Ventures Inc.

PUF Ventures Announces Closing of Plan of Arrangement with Cannvas Medtech Inc.

VANCOUVER, Jan. 16, 2018 /CNW/ – PUF Ventures Inc. (“PUF” or the “Company“) (CSE: PUF) (Frankfurt: PU3) (OTCPK: PUFXF), and Cannvas Medtech Inc. (“MTEC“) are pleased to announce that on January 16, 2018 (the “Effective Date“), they completed a statutory arrangement under a […]